BOOK NOW

Agenda

Registration and morning refreshments
SESSION 1: A REVIEW AND UPDATE FROM ENDS 2022
Review of recent literature about emission characterisation: New standard required
▪ Summary of two critical reviews about emission analysis
▪ State of standardization related to emission
▪ Future development required
Sébastien Soulet | Research Scientist, Ingésciences
Development of a novel device for standardised e-liquid testing – new insights
▪ Development of a new device for standardised e-liquid testing
▪ Testing with the device should ensure that especially temperature-labile substances and potentially toxic decomposition products are detected during routine testing
▪ Presentation of device and analytical results
Dr Stefanie Scheffler | Scientist, Fraunhofer Institute for Toxicology and Experimental Medicine
SESSION 2: A EUROPEAN OUTLOOK ON POLICY, REGULATION AND IMPACT
The alternative smoke-free plan
Offering a series of liberal, evidence-based policy recommendations for national governments and the EU to help them achieve their smoking reduction targets.
▪ Correcting misinformation about vaping
▪ Amending legislation to address market failures
▪ Regulating reduced risk products in a way that encourages switching from cigarettes
▪ Developing an innovation principle
Christopher Snowdon | Head of Lifestyle Economics, Institute of Economic Affairs (IEA)
Morning networking break
EU regulatory updates (Tobacco Excise Duty Directive, Tobacco Products Directive, New Batteries Directive)
▪ EU regulatory updates
▪ Tobacco Excise Duty Directive, Tobacco Products Directive, New Batteries Directive
▪ IEVA code for responsible marketing
Ciprian Boboi | Founder and Board Member, Independent European Vape Alliance (IEVA)
EU overview: market and regulatory trends about alternative tobacco and nicotine products
▪ Overview of the current EU market
▪ Regulatory impact and emerging novel products
▪ Regulatory and policy trends and forecast
▪ Enforcement issue
Marija Obradovic | Head Legal Analyst, ECigIntelligence
Networking lunch
Panel discussion: The future of tobacco taxation in Europe
▪ Early reports indicate that the EU will propose a significant increase to the existing minimum cigarette tax rates and expand the product categories that are taxed, including a block-wide vaping tax. With key industry perspectives, this panel will explore the potential impacts of taxation, what is likely to change and what this means for industry going forward

Panel moderators:
▪ Robert Sidebottom, Managing Director, Arcus Compliance

Panellists:
▪ Martin Cullip, International Fellow, Taxpayers Protection Alliance Consumer Center
▪ Bas Tonnaer, Managing Partner, Rothman & Roman
▪ Chris Snowdon, Head of Lifestyle Economics, Institute of Economic Affairs (IEA)
Nicotine - Why the villain complex?
▪ Using nicotine is an ancient human habit - spanning tens of thousands of years
▪ Nicotine has been used safely for 50 years in medicines
▪ Regulation needs to recognise that decoupling nicotine from smoke removes much of the risk
▪ We must keep the innovation window open if modern nicotine products are to realise their potential in tobacco harm reduction
Dr Marina Murphy | Director, ANDS
Panel discussion: Consumer product comparisons – vaping vs other age restricted products
▪ This panel will explore the different perceptions on vaping compared to other age-restricted products in terms of enforcement, marketing and compliance.

Panel moderator:
Robert Sidebottom, Managing Director, Arcus Compliance

Panellists:
Mark Oates, Director, We Vape
Jeannie Cameron, CEO, JCIC International
John Dunne, Director General, UK Vaping Industry Association
Afternoon networking break
SESSION 3: FLAVOURS – SOLVING TOXICOLOGICAL CONCERNS
Data driven overview of the impact of an ENDS flavour ban and the importance of product specific prevalence of use estimates
▪ What flavours do youth and adult current smokers use
▪ How an ENDS flavour ban could impact youth and adult current smokers
▪ How can product specific prevalence of use estimates support your PMTA submission
Dr Andrea Patton | Behavioural Epidemiologist (Head of Prevalence Research), Centre for Substance Use Research Ltd
Flavours matter and prohibition doesn't work!
▪ Role of flavours for adults and the importance for smoking cessation
▪ Overview of effects of existing flavour bans (Netherlands will be addressed here)
▪ Addressing the youth protection argument
▪ Prohibition in general and what further effects flavour bans will have
Michael Landl | Director, World Vapers' Alliance
Toxicological assessment of e-liquid flavours
▪ Hazard screening of e-liquid ingredients
▪ Preparation of toxicological profiles (e.g. TPD-compliant)
▪ Hazard characterisation and toxicity concerns
▪ Risk/safety assessment of flavours
Richard Young | Principal Toxicologist and Managing Director, , Bibra toxicology advice & consulting Ltd.
Networking drinks reception
Registration and morning refreshments
SESSION 4: A GLOBAL OUTLOOK ON REGULATION, POLICY AND IMPACT
Will WHO FCTC COP 10 in November be a make or break COP for the global nicotine market?
▪ WHO strategy against tobacco harm reduction and the nicotine industry
▪ The key policy and scientific issues on the agenda for COP10
▪ Preparing for COP10 in November 2023
Jeannie Cameron | CEO, JCIC International
Comparative global policy directions impacting ENDS
▪ What are the main regulatory trends in ENDS harm reduction?
▪ Which regulatory approaches best serve tobacco harm reduction?
▪ Opportunities to reshape ENDS regulatory approaches
Patricia I. Kovacevic | General Counsel, Cryomass Technology Inc. and Principal, RegulationStrategy
SESSION 5: TOBACCO HARM REDUCTION – AN OPTIMISTIC APPROACH
Reasons to be cheerful
▪ Evidence base going in favour of harm reduction
▪ A beachhead has been established and we are now gaining ground
▪ The huge effort consumers have put in means we have the audience on our side
Tom Gleeson | Trustee, NNA Ireland
Morning networking break
Tobacco transformation: Bold steps towards a better tomorrow
▪ The role of reduced risk products in tobacco harm reduction policy
▪ The challenges in the adoption of tobacco harm reduction
▪ Enabling policy environment that will accelerate tobacco transformation
Flora Okereke | Head of Regulatory Insights and Foresights, BAT
SESSION 6: TACKLING CONCERNS AROUND INDUSTRY STANDARDS
Networking lunch
Inhalation preclinical assessment: In vitro science for real life user
▪ Pros and cons of evidence on flavour inhalation
▪ GRAS when vaped: regulatory overview
▪ Translating real-life usage to in-vitro
Rosalia Emma | Assistant Professor, Department of Clinical and Experimental Medicine, University of Catania
SESSION 7: MEDICINAL LICENSING FOR E-CIGARETTES
Licensed E-Cigarettes on prescription: The greatest unmet need in smoking cessation and tobacco control
▪ Brief history of licensing E-Cigarettes as medicines
▪ Overview of global routes to market: how to navigate regulatory pathways
▪ Permissive and pragmatic vs. restrictive regulatory regimes
▪ Pros and cons of ENDS licensing – consumers and manufacturers
Ian Fearon | Director, whatIF? Consulting Ltd
Developing an ENDS product for medicinal licensing
▪ Product development process
▪ Materials/technology selection
▪ Specific product functionality requirements
▪ Design areas to focus on to improve the chances of the ENDS products complying with regulatory requirements
▪ Emerging technologies and how they may help an ENDS product obtain a medicinal license
Pete Lomas | Managing Consultant – Product Realization, Broughton
SESSION 8: BREAKTHROUGH PRODUCTS AND TECHNOLOGIES
Assessing the real-world e-cigarette actual use behaviours in real-time empowered by a novel puff recording electronic nicotine delivery system (VITRO®)
▪ VITRO® as a novel puff recording ENDS for monitoring e-cigarette actual use: Introduction, Validation of puff recording feature (experimental & clinical)
▪ Real-time, real-world e-cig use behaviours empowered by VITRO®
▪ Implications for industry, regulations, and public health: The interplay between devices and e-liquid, especially nicotine strengths, Intra- and interindividual variabilities of e-cig use behaviours
Xiang Gao | Principal Scientist, Scientific Horizons Consulting (SHC)
Flavour preferences among nicotine pouch users in US and Europe
▪ Groups 790 000 nicotine pouch users
▪ Sex, age, smokers and non-smokers
▪ Attractiveness and the unintended quitters
 
Markus Lindblad | Head of External Affairs, Haypp Group
Chair's summary and close of conference
ENDS-EUROPE-2023-AGENDA-3-5-23